Project Details
Abstract
The purpose of this project is to develop a material of magnetic nanoparticles (MNPs)
that could carry the drugs for accelerating the dissolving of thrombolysis. One or two
drugs such as thrombolytic drug (rt-PA), anticoagulants (Heparin), and antiplatelet drug
(Tirofiban) are bound to the surfaces of MNPs and guided by the applied external magnet
for concentration effective and targeted therapy.
This is a 2 year project, which comprises the following research topics:
1. Synthesis the water solvable Fe3O4 nanoparticles with various sizes and characterize
their structural and physical properties.
2. Synthesis the water suspension core/shell nanoparticles, Fe3O4/Poly(ethylene
Oxide-acylic acid) (PEA) and Fe3O4/polyethylene oxide-polyacylic acid blend (PEAB).
The above mentioned drugs can be bound on the surface of Fe3O4/PEA and
Fe3O4/PEAB nanoparticles by covalent bonding and dispersed uniformly in water.
Structural and physical properties of Fe3O4/PEA and Fe3O4/PEAB nanoparticles are
characterized and correlated to their in-vitro therapy effect.
3. Activity analysis of Fe3O4, Fe3O4/PEA and Fe3O4/PEAB nanoparticles binding with
drugs.
4. Cytotoxicity assay of Fe3O4, Fe3O4/PEA and Fe3O4/PEAB nanoparticles binding with
drugs.
5. In-vitro thrombolysis of Fe3O4/PEA and Fe3O4/PEAB nanoparticles binding with drugs.
Project IDs
Project ID:PB9912-1073
External Project ID:NSC99-2221-E182-068
External Project ID:NSC99-2221-E182-068
Status | Finished |
---|---|
Effective start/end date | 01/08/10 → 31/07/11 |
Keywords
- Thrombolysis
- Recombinant tissue plasminogen activator (rtPA)
- Magnetic nanocarriers
- Magnetic targeting
- Targeting therapy
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.